Ronald E. Bruehlman - 01 Jan 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role: Director
Signature: /s/ Gracye Cheng, Attorney-in-Fact for Ronald E Bruehlman
Issuer symbol: GDRX
Transactions as of: 01 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Jan 2025, 19:07:48 UTC
Previous filing: 12 Nov 2024
Next filing: 30 Jan 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GDRX	Class A Common Stock	Award	$0	+10,653	+49%	$0.000000	32,284	01 Jan 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).

Content

Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in substantially equal monthly installments beginning on January 31, 2025 and ending on December 31, 2025, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2030; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).